Use the Search Fields to Find Information
Page 79 of 348
Probing the antioxidant activity of Δ9-tetrahydrocannabinol and cannabidiol in Cannabis sativa extracts
Please use this link to access this publication. Abstract Herein, we report the antioxidant activity of cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) in pure and mixed
August 1, 2024
Proapoptotic effect of endocannabinoids in prostate cancer cells
In the early stages, prostate cancer is androgendependent; therefore, medical castration has shown significant results during the initial stages of this pathology. Despite this early
September 19, 2019
Pro-resolution, Protective and Anti-Nocieptive Effects of a Cannabis Extract in the Rat Gastrointestinal Tract
Cannabis is widely used for treating a number of gastrointestinal ailments, but its use is associated with several adverse effects, particularly when the route of
Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9 – Tetrahydrocannabinol
Abstract Objective: Acute administration of cannabinoid CB1 receptor agonists, or the ingestion of cannabis, induces short-term hyperphagia. However, the incidence of obesity is lower in
August 24, 2023
Prevalence of Medical Cannabis Use and Associated Health Conditions Documented in Electronic Health Records Among Primary Care Patients in Washington State
Abstract Importance Many people use cannabis for medical reasons despite limited evidence of therapeutic benefit and potential risks. Little is known about medical practitioners’ documentation of
June 16, 2025
Prevalence of Marijuana Use Disorders in the United States Between 2001–2002 and 2012–2013
Abstract IMPORTANCE Laws and attitudes toward marijuana in the United States are becoming more permissive but little is known about whether the prevalence rates of
November 9, 2023
Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids
Please use this link to access this publication. Abstract Importance Cannabis withdrawal syndrome (CWS)—a diagnostic indicator of cannabis use disorder—commonly occurs on cessation of heavy and
September 25, 2025
Prevalence of cannabis use, disorder, and medical card possession in U.S. military veterans: Results from the 2019–2020 National Health and Resilience in Veterans Study
Please use this link to access this publication. Abstract More than half of U.S. states legalized medical or recreational sale and possession of cannabis since
July 5, 2025
Prevalence of cannabis use among individuals with a history of cancer in the United States
Abstract Background Patients with cancer have played a key role in advocating for legal access to cannabis, but little is known about links between cancer
September 6, 2025
Prevalence of Cannabinoid Use in Patients With Hip and Knee Osteoarthritis
Abstract Introduction: State legalization and widespread marketing efforts have increased the accessibility and consumption of off-label, non–FDA-approved, cannabinoid (CBD) products. Although clinical evidence is largely
April 16, 2024
Page 79 of 348